Research on Reimbursement of Therapeutic Medical Device through Delphi Method and Analytic Hierarchy Process
![]() |
Noh, Jin-Won
(Department of Healthcare Management, Eulji University)
Lee, Yejin (Department of Healthcare Management, Eulji University) Jang, Suk Yong (Department of Preventive Medicine, College of Medicine, Eulji University) Kim, Mi Kyung (Department of Medical cost management, Bundang Medical Center, CHA University) Cho, Kyoung Hee (Department of Public Health, Yonsei University) Kim, Jae-Hyun (Department of Health Administration, Dankook University) Yoo, Ki-Bong (Department of Health Administration, Department of Information& Statistics, Yonsei University) |
1 | Health Insurance Review & Assessment Service. 2016 Trends and prospects of therapeutic medical device. Health Insurance Review & Assessment Service 2016. |
2 | Lee KD. Experiences and Tasks of the Medical Device Expert Evaluation Committee. HIRA Policy Trend 2012;6(3):21-31. |
3 | Lee SS, Salole E. Medical Device Reimbursement Coverage and Pricing Rules in Korea: Current Practice and Issues with Access to Innovation. Value In Health 2014;17:476-481. DOI |
4 | Lee CS, Kang GW, Byun SA. Revision Research Report of Relative Value Based Scale. Health Insurance Review & Assessment Service 2006. |
5 | Ministry of Health and Welfare. Reduce outpatient copayment for singlue use syringe and endoscope disinfection. Ministry of Health and Welfare press release. 2016 Nov 4. |
6 | Busse R, Geissler A, Quentin W, Wiley M. Diagnosis-Related Groups in Europe. European Observatory on Health Systems and Policies;2011. |
7 | Lawshe CH. A quantitative approach to content validity. Personnel psychology 1975;28:563-575. DOI |
8 | Lee SS, Symonds D, Kamogawa S, Sato M, Chiang E, Salole E. Reimbursement Coverage and Pricing Systems for Single-Use Devices in Asia-Pacific: Japan, Taiwan, Korea, and Australia Compared. Value In Health 2015;6C:126-129. |
9 | Sorenson C, Kanavos P. Financing Medical Devices in France and the UK. European Health Technology Institute on Socio-Economic Research;2014. |
10 | Haute Autorite de Sante. Medical device assessment in France. Haute Autorite de Sante;2009. |
11 | Iglesias CP. Does assessing the value for money of therapeutic medical devices require a flexible approach? Expert Rev. Pharmacoecon. Outcomes Res 2015;15(1):21-32. DOI |
12 | Frigerio M. Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Eur Respir Rev 2016;25:223-226. DOI |
13 | Martelli N, Devaux C, van den Brink H, Pineau J, Prognon P, Borget I. A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty. Plos One 2015;10(12):e0144892. DOI |
14 | Schnell-Inderst P, Hunger T, Condrads-Frank A, Arvandi M, Siebert U. Recommendations for primary studies evaluating therapeutic medicaldevices were identified and systematically reported through reviewingexisting guidance. J Clin Epidemiol 2018;94:46-58. DOI |
15 | Chen W, Yu J, Zhang L, Su G, Wang W, Kwong J, Sun X, Li Y. Quality of reporting in randomized controlled trials of therapeutic cardiovascular medical devices. Surgery 2018;https://doi.org/10.1016/j.surg.2018.09.010. DOI |
16 | Venkatesh MP, Bandla DT. Regulatory Assessment of Premarket Approval of Medical Devices in US and EU. IJPCR 2017;9(4):281-285. |
17 | FDA. Use of Real-World Evidence to support regulatory decision-making for medical devices. U.S. Department of Health and Human Services Food and Drug Administration; 2017. |
18 | NICE. Medical technologies evaluation programme methods guide. National Institute for Health and Care Excellence; 2017. |
19 | HAS. Manufacturer's Guide. Haute Autorite de Sante; 2011. |
20 | Fuchs S, Olberg B, Panteli D, Perleth M, Busse R. HTA of medical devices: Challenges and ideas for the future from a European perspective. Health Policy 2017;121:215-229. DOI |
21 | Schnell-Inderst P, Hunger T, Condrads-Frank A, Arvandi M, Siebert U. Ten recommendations for assessing the comparative effectiveness oftherapeutic medical devices: a targeted review and adaptation. J Clin Epidemiol 2018;94:97-113. DOI |
22 | Zannad F, Garcia MAA, Borer JS, Stough WG, Clutton-Brock T, Rosenberg Y, Packer M. Role of Payers in the Development of Cardiovascular Therapeutics. JACC 2017;70(22):2822-2830. DOI |
![]() |